Abstract

The peripheral hearing process taking place in the cochlea mainly depends on two distinct sensory cell types: the mechanosensitive hair cells and the spiral ganglion neurons (SGNs). The first respond to the mechanical stimulation exerted by sound pressure waves on their hair bundles by releasing neurotransmitters and thereby activating the latter. Loss of these sensorineural cells is associated with permanent hearing loss. Stem cell-based approaches aiming at cell replacement or in vitro drug testing to identify potential ototoxic, otoprotective, or regenerative compounds have lately gained attention as putative therapeutic strategies for hearing loss. Nevertheless, they rely on efficient and reliable protocols for the in vitro generation of cochlear sensory cells for their implementation. To this end, we have developed a differentiation protocol based on organoid culture systems, which mimics the most important steps of in vivo otic development, robustly guiding mouse embryonic stem cells (mESCs) toward otic sensory neurons (OSNs). The stepwise differentiation of mESCs toward ectoderm was initiated using a quick aggregation method in presence of Matrigel in serum-free conditions. Non-neural ectoderm was induced via activation of bone morphogenetic protein (BMP) signaling and concomitant inhibition of transforming growth factor beta (TGFβ) signaling to prevent mesendoderm induction. Preplacodal and otic placode ectoderm was further induced by inhibition of BMP signaling and addition of fibroblast growth factor 2 (FGF2). Delamination and differentiation of SGNs was initiated by plating of the organoids on a 2D Matrigel-coated substrate. Supplementation with brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) was used for further maturation until 15 days of in vitro differentiation. A large population of neurons with a clear bipolar morphology and functional excitability was derived from these cultures. Immunostaining and gene expression analysis performed at different time points confirmed the transition trough the otic lineage and final expression of the key OSN markers. Moreover, the stem cell-derived OSNs exhibited functional electrophysiological properties of native SGNs. Our established in vitro model of OSNs development can be used for basic developmental studies, for drug screening or for the exploration of their regenerative potential.

Highlights

  • Spiral ganglion neurons (SGNs) within the cochlea play a central role for sound perception, providing afferent neurotransmission to the central auditory system

  • No 16141061), 1 mM of penicillin/streptomycin, 1 mM of non-essential amino acid, 0.1 mM of 2-mercaptoethanol, and 1,000 U ml−1 leukemia inhibitory factor (LIF). mouse embryonic stem cells (mESCs) were incubated at 37◦C with 5% CO2 overnight, before medium was changed to 100% LIF-2i on the following day

  • On day 3, the aggregates were further guided to differentiate to non-neural ectoderm (NNE) by activating BMP4 signaling

Read more

Summary

Introduction

Spiral ganglion neurons (SGNs) within the cochlea play a central role for sound perception, providing afferent neurotransmission to the central auditory system. Upon activation, they encode frequency, duration, and intensity of all sounds and relay this information to the brain stem and further to higher auditory centers (Appler and Goodrich, 2011; Dabdoub et al, 2016). SGNs, much like cochlear hair cells, are sensitive to insults, including noise overexposure, and do not regenerate after cell death. Their loss leads to permanent hearing deficit (Lang, 2016). Retrospective studies revealed a correlation between the SGN density and the success of the implant (Blamey, 1997; Incesulu and Nadol, 1998; Fayad and Linthicum, 2006)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call